Delivery Order SPE2DB25D9348-SPE2DB25FNMVG
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc. for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge location with an ultimate completion date of September 10, 2025. This delivery order was awarded without a set-aside designation on September...
- The Defense Logistics Agency awarded a $36,976.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on June 6, 2025, with an ultimate completion date of June 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform this delivery order from its Park Ridge, Illinois...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 4, 2025, was issued without set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency awarded a $18,474.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Trikafta 50-25-37.5 mg/75 mg tablets (84-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order was issued without a set-aside designation and will be performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime...
- The Defense Logistics Agency awarded a $26,827.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $18,474.02 to DMS Pharmaceutical Group Inc. on August 12, 2025, for the supply of Trikafta 50-25-37.5 mg/75 mg tablets (84-count units). This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency on September 18, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The contract utilizes firm fixed-price pricing and carries an ultimate completion date of September 19, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to...
- The Defense Logistics Agency awarded a $77,266.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Trikafta 100-50-75 mg/75 mg packets in quantities of 14, with an ultimate completion date of April 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled from the company's Park Ridge facility. This award is issued under DMS...
- SPE2DB25D9348Indefinite Delivery Contract
- SPE2DB25D9348-SPE2DB25FNMVGDelivery Order
The Defense Logistics Agency awarded a $36,976.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its facility in Park Ridge. The contract carries an ultimate completion date of July 24, 2025, and no set-aside designation was utilized in this award. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. As an established supplier in the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group regularly delivers prescription medications, biologics, and medical consumables to military health facilities. Trikafta, a prescription medication used in the treatment of cystic fibrosis, represents one of many specialized pharmaceutical products the contractor supplies through this strategic partnership with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.0k | 7/23/25 |